Type 1 IFN Function and Signaling in Immunity to Viruses
1 型干扰素在病毒免疫中的功能和信号传导
基本信息
- 批准号:7148056
- 负责人:
- 金额:$ 36.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-15 至 2008-09-14
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigensAntiviral AgentsBiologicalBiologyCD8B1 geneCellsGene ExpressionGene TargetingGoalsImmuneImmune responseImmunityImmunodeficiency and CancerIn VitroInfectionInterferon ActivationInterferon Type IIInterferon-alphaInterferonsLeadLinkLymphocytic choriomeningitis virusMediatingPathway interactionsPhosphorylationPopulationProductionRangeReadinessRegulationResistance to infectionRoleSTAT proteinSTAT1 geneSTAT1 proteinSTAT2 geneSTAT4 geneShapesSignal PathwaySignal TransductionT cell regulationT-Cell ProliferationT-LymphocyteTerrorismTestingTherapeutic InterventionVirusVirus DiseasesWorkbasecytokinedefined contributionin vivoinsightnovelresearch studyresponse
项目摘要
The innate cytokines, type 1 interferons (IFN), including interferons alpha and beta, were first identified by
their anitiviral functions. It is now know that they also mediate a wide range of immunoregulatory effects.
Certain of these are paradoxical, and mechanisms controlling the subset of effects induced following IFN-
alpha/beta exposure remain to be elucidated. Likewise, CD8 T cell regulation is incompletely understood, but
dramatic CD8 T cell responses are observed during viral infections eliciting high concentrations of type 1
IFNs. This project will test the primary hypotheses that the type 1 IFN effects elicited are controlled by
regulation of access to different intracellular signaling pathways, and that this regulation is required and
delivered during innate and adaptive immune responses to viral infections. Thus, these hypotheses present
a picture of "Type 1 Interferons as Links Between Innate and Adaptive Immune Responses to Viral
Infections". Based on our studies of functions for signal transducers and activators of transcription (STAT) 1
and STAT4 following infections with lymphocytic choriomeningitis virus (LCMV) and treatments with
cytokines, regulation of STAT1 is proposed to be a critical mechanism for switching to different responses
following type 1 IFN exposure. Focus of the planned experiments will be on effects for induction of antiviral
state, IFN-alpha/beta amplification, and the CD8 T cell IFN-gamma production and proliferative responses.
The work will be accomplished in three specific aims. Aim 1 wilt evaluate the infection-induced changes in
type 1 IFN effects for target gene expression. Aim 2 will define STAT functions in pathways shaping the
biological effects mediatd by type 1 IFNs. This aim will address consequences downstream of STATs. Aim 3
will mechnistically advance understanding of how the STATs are regulated to promote particular effects. As
these studies are driven by characterization of in vivo biology, their results are likely to lead to discovery of
novel pathways not predicted by in vitro studies atone. They will contribute to the understanding of the
factors, particularly the innate immune components, promoting resistance to infections. They also promise to
provide insights for approaches to therapeutic intervention in the treatment of infections, cancers, and
immunodeficiencies. The information derived from this work will help in devising plans for readiness and
defense against biD-terrorism.
先天的细胞因子,1型干扰素,包括干扰素α和β,首先被鉴定为
它们的抗病毒功能。现在已经知道,它们还调节一系列广泛的免疫调节效应。
其中某些是矛盾的,控制干扰素-2诱导的效应子集的机制-
阿尔法/贝塔暴露仍有待阐明。同样,CD8 T细胞的调节也不完全清楚,但
在引起高浓度1型病毒感染期间观察到戏剧性的CD8 T细胞反应
IFN。该项目将检验第一型干扰素效应受以下因素控制的基本假设
对不同细胞内信号通路的调节,并且这种调节是必需的,并且
在对病毒感染的先天和获得性免疫反应期间提供。因此,这些假设提出了
I型干扰素是病毒先天免疫反应和获得性免疫反应之间的纽带
基于我们对信号转导和转录激活子(STAT)功能的研究1
和STAT4在感染淋巴细胞性脉络膜脑膜炎病毒(LCMV)和治疗后
细胞因子,STAT1的调节被认为是切换到不同反应的关键机制
在暴露于1型干扰素之后。计划中的实验重点将放在抗病毒诱导的效果上。
状态,干扰素-α/β扩增,以及CD8T细胞干扰素-γ的产生和增殖反应。
这项工作将按三个具体目标完成。目的1将评估感染诱导的变化。
1型干扰素对靶基因表达的影响。目标2将定义STAT函数在塑造
1型干扰素介导的生物学效应。这一目标将解决统计数据下游的后果。目标3
是否会从机械上促进对如何监管统计数据以促进特定效果的理解。AS
这些研究是由体内生物学的特征驱动的,他们的结果可能会导致发现
体外研究没有预测到的新途径赎罪了。他们将有助于理解
促进抵抗感染的因素,特别是先天免疫成分。他们还承诺
为感染、癌症和癌症的治疗干预方法提供见解
免疫缺陷。从这项工作中获得的信息将有助于制定准备计划和
对投标恐怖主义的防御。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTINE A. BIRON其他文献
CHRISTINE A. BIRON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTINE A. BIRON', 18)}}的其他基金
NK Cell STAT3 and Virus-induced IL-6 Disease
NK 细胞 STAT3 和病毒诱导的 IL-6 疾病
- 批准号:
9352931 - 财政年份:2016
- 资助金额:
$ 36.5万 - 项目类别:
Type 1 IFN Function and Signaling in Immunity to Viruses
1 型干扰素在病毒免疫中的功能和信号传导
- 批准号:
7682782 - 财政年份:2008
- 资助金额:
$ 36.5万 - 项目类别:
EVENTS REGULATING THE BALANCE BETWEEN RESISTANCE & INFECTION
调节阻力平衡的事件
- 批准号:
7170316 - 财政年份:2005
- 资助金额:
$ 36.5万 - 项目类别:
EVENTS REGULATING THE BALANCE BETWEEN RESISTANCE & INFECTION
调节阻力平衡的事件
- 批准号:
7011753 - 财政年份:2004
- 资助金额:
$ 36.5万 - 项目类别:
Type 1 IFN Function and Signaling in Immunity to Viruses
1 型干扰素在病毒免疫中的功能和信号传导
- 批准号:
6671292 - 财政年份:2003
- 资助金额:
$ 36.5万 - 项目类别:
Type 1 IFN Function and Signaling in Immunity to Viruses
1 型干扰素在病毒免疫中的功能和信号传导
- 批准号:
8309406 - 财政年份:2003
- 资助金额:
$ 36.5万 - 项目类别:
Type 1 IFN Function and Signaling in Immunity to Viruses
1 型干扰素在病毒免疫中的功能和信号传导
- 批准号:
6758522 - 财政年份:2003
- 资助金额:
$ 36.5万 - 项目类别:
Type 1 IFN Function and Signaling in Immunity to Viruses
1 型干扰素在病毒免疫中的功能和信号传导
- 批准号:
8112698 - 财政年份:2003
- 资助金额:
$ 36.5万 - 项目类别:
Type 1 IFN Function and Signaling in Immunity to Viruses
1 型干扰素在病毒免疫中的功能和信号传导
- 批准号:
7787580 - 财政年份:2003
- 资助金额:
$ 36.5万 - 项目类别:
Type 1 IFN Function and Signaling in Immunity to Viruses
1 型干扰素在病毒免疫中的功能和信号传导
- 批准号:
6824915 - 财政年份:2003
- 资助金额:
$ 36.5万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 36.5万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 36.5万 - 项目类别: